UBC’s School of Biomedical Engineering and Amgen Bring the Amgen Golden Ticket to Canada
The program has selected two ventures that will receive dedicated wet laboratory space, equipment, building services, and mentorship at the SBME Innovates incubator.
Making Organ Transplants Safer
Dr. Megan Levings and her team are training the immune system to tolerate invaders. Their work could reduce the need for immunosuppressive drugs — and vastly improve patients’ quality of life.
SBME Capstone Industry Projects
For the biomedical engineering students at UBC, their final graduating requirement is the completion of the BMEG 457 Capstone Design Project. The eight-month capstone project features teams of four to five students and is client-focused (i.e. the organizations sponsor the projects). Capstone projects rise from real-world data, challenges and advancements. The goal may not be a refined solution to a presented problem, but identifying a viable path to follow. Submission for Capstone Industry Projects is open June 1 - July 25, 2022
Applications for the Creative Destruction Lab are Open
The Creative Destruction Lab (CDL) is a nine-month early-stage program for science and technology-driven startups. At the core of the program are five intensive, full-day summit meetings that happen every eight weeks, where founders meet a curated group of investors, successful tech entrepreneurs, and technologists to set short-term objectives and raise capital.
FIFTEEN UBC RESEARCHERS ANNOUNCED AS NEW AND RENEWED UBC CANADA RESEARCH CHAIRS
Fifteen UBC researchers were announced as new and renewed Canada Research Chairs in the latest round of appointments.
Venture Founder: Lab2Launch
For UBC researchers and scientists focusing on innovations that will advance the future of our world. Lab2Launch supports UBC researchers and scientists who plan to build, or are building, a deep tech venture based on a proprietary and novel scientific or technological innovation. Participants in this stream will dive deep into the DNA of their venture opportunity, articulating the problem they are solving, identifying who experiences this problem, and why the proposed solution is the preferred market opportunity.
UBC Medicine community members recognized for advancing B.C. as a global leader in clinical trials
On May 19, members of the UBC Medicine community were recognized by Clinical Trials BC for outstanding contributions to clinical trials and health research in the province.
UBC Medicine researchers awarded 2022 Innovation and Translational Research Awards
Six researchers from UBC Medicine have been awarded 2022 Innovation and Translational Research Awards from the Vancouver Coastal Health Research Institute (VCHRI).
Dr. Dean Regier appointed Co-Director pro tem for the Academy of Translational Medicine
We are delighted to announce the appointment of Dr. Dean Regier as Co-Director pro tem for the Academy of Translational Medicine (ATM) while Dr. Poul Sorensen is on sabbatical at Technical University of Munich.